Old versus New: Why Do We Need New Antiepileptic Drugs?
Journal of Epilepsy Research · 2014-12-31 · 4 (2) · 39-44
DOI: 10.14581/jer.14010 ↗At a glance
Übersichtsarbeit in Journal of Epilepsy Research, published online on 2014-12-31. Written by Sang Kun Lee. Institution: Department of Neurology, Seoul National University College of Medicine, Seoul, Korea. Cited 55 times so far (Crossref); 24 references. The full text is freely available in PubMed Central.
Abstract (original language)
Achieving complete seizure remission without adverse events is the goal of epilepsy treatment. Recently, many new antiepileptic drugs (AEDs) have been developed. Even though the efficacy of new AEDs is not stronger than that of old AEDs, there are advantages in using new AEDs. They have unique or different mechanisms of action that enable the creation of possible synergistic combinations. They usually exhibit fewer or no pharmacokinetic drug interactions. Furthermore, the response to AEDs varies individually. A similar efficacy does not imply a similar response from all patients. Many new AEDs have fewer adverse events, including induction of congenital malformations. Other concerns about the long-term effects of established AEDs, such as bone health and development of atherosclerosis, may be alleviated by the use of new AEDs. New AEDs are needed to achieve better care of patients with epilepsy.
Subjects
Author keywords
Authors and institutions
- Department of Neurology, Seoul National University College of Medicine, Seoul, Korea.
Cite
APA
Lee, S. K. (2014). Old versus New: Why Do We Need New Antiepileptic Drugs?. Journal of Epilepsy Research, 4(2), 39-44. https://doi.org/10.14581/jer.14010
Vancouver
Lee SK. Old versus New: Why Do We Need New Antiepileptic Drugs?. Journal of Epilepsy Research. 2014;4(2):39-44. doi:10.14581/jer.14010
BibTeX
@article{Lee2014,
author = {Lee, Sang Kun},
title = {Old versus New: Why Do We Need New Antiepileptic Drugs?},
journal = {Journal of Epilepsy Research},
year = {2014},
volume = {4},
number = {2},
pages = {39--44},
doi = {10.14581/jer.14010}
}
EUVIMED